BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Diagnosis
35 results:

  • 1. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target.
    Ren LK; Lu RS; Fei XB; Chen SJ; Liu P; Zhu CH; Wang X; Pan YZ
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):127. PubMed ID: 38483604
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A case of esophageal squamous cell carcinoma accompanied by pancreatic and bile duct metastases: Successful treatment starts with an accurate diagnosis.
    Ito Y; Ikura Y; Sawai H; Osuga T
    J Cancer Res Ther; 2023 Oct; 19(7):2060-2063. PubMed ID: 38376319
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Blockade of DDR1/PYK2/erk signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer.
    Xu H; Tan M; Hou GQ; Sang YZ; Lin L; Gan XC; Cao X; Liu AD
    Cell Death Dis; 2023 Dec; 14(12):811. PubMed ID: 38071340
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Adamantinoma-like ewing sarcoma arising in the pancreatic tail: a case report of a rare entity and review of the literature.
    Wang Z; Wen X; Zhang Y; Zhang X
    Diagn Pathol; 2023 Jul; 18(1):86. PubMed ID: 37518334
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. GABRP Promotes the Metastasis of pancreatic cancer by Activation of the MEK/erk Signaling Pathway.
    Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
    Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Crosstalk between circRNAs and the PI3K/AKT and/or MEK/erk signaling pathways in digestive tract malignancy progression.
    Wu C; Huang X; Li M; Wang Z; Zhang Y; Tian B
    Future Oncol; 2022 Dec; 18(40):4525-4538. PubMed ID: 36891896
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in pancreatic Adenocarcinoma.
    Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Gene Differential Expression and Interaction Networks Illustrate the Biomarkers and Molecular Biological Mechanisms of Unsaponifiable Matter in Kanglaite Injection for pancreatic Ductal Adenocarcinoma.
    Xu B; Dan W; Zhang X; Wang H; Cao L; Li S; Li J
    Biomed Res Int; 2022; 2022():6229462. PubMed ID: 35707377
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Moving Towards Dawn: KRas Signaling and Treatment in pancreatic Ductal Adenocarcinoma.
    Rajpurohit T; Bhattacharya S
    Curr Mol Pharmacol; 2022; 15(7):904-928. PubMed ID: 35088684
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dysfunction of miR-802 in tumors.
    Gao T; Zou M; Shen T; Duan S
    J Clin Lab Anal; 2021 Nov; 35(11):e23989. PubMed ID: 34558723
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer.
    Qureshi Z; Ahmad M; Yang WX; Tan FQ
    Biochem Biophys Res Commun; 2021 Oct; 576():7-14. PubMed ID: 34474246
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of erk signaling in pancreatic cancer.
    Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
    Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Primary squamous cell carcinoma of the pancreas with a large pseudocyst of the pancreas as the first manifestation: a rare case report and literature review.
    Qiu X; Meng Y; Lu M; Tian C; Wang M; Zhang J
    BMC Gastroenterol; 2021 May; 21(1):208. PubMed ID: 33964875
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma.
    Zhu P; Feng R; Lu X; Liao Y; Du Z; Zhai W; Chen K
    Aging (Albany NY); 2021 Jan; 13(3):4138-4156. PubMed ID: 33493134
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer.
    Sarwar A; Wang B; Su Q; Zhang Y
    Biochem Pharmacol; 2021 Jul; 189():114357. PubMed ID: 33279497
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2.
    Li XL; Li SZ; Wu CX; Xing XH
    Kaohsiung J Med Sci; 2021 Apr; 37(4):294-304. PubMed ID: 33236530
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pan-p63 but not ΔNp63 (p40) expression in undifferentiated carcinoma of the pancreas.
    Liszka Ł
    Pol J Pathol; 2020; 71(2):155-172. PubMed ID: 32729306
    [TBL] [Abstract] [Full Text] [Related]  

  • 18.
    Valencia-Sama I; Ladumor Y; Kee L; Adderley T; Christopher G; Robinson CM; Kano Y; Ohh M; Irwin MS
    Cancer Res; 2020 Aug; 80(16):3413-3423. PubMed ID: 32586982
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Broussoflavonol B from
    Jeong JH; Ryu JH
    Molecules; 2020 May; 25(10):. PubMed ID: 32429421
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers.
    Wang J; Nishiyama A; Matsuyama M; Wang Z; Yuan Y
    Cell Commun Signal; 2020 Mar; 18(1):39. PubMed ID: 32143717
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.